Literature DB >> 18606244

Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cells.

Ivan Tattoli1, Luigi Lembo-Fazio, Giulia Nigro, Leticia A M Carneiro, Elisabetta Ferraro, Giacomo Rossi, Maria Celeste Martino, Maria Egle de Stefano, Francesco Cecconi, Stephen E Girardin, Dana J Philpott, Maria Lina Bernardini.   

Abstract

Infected epithelial cells, which act as a first barrier against pathogens, seldom undergo apoptosis. Rather, infected epithelial cells undergo a slow cell death that displays hallmarks of necrosis. Here, we demonstrate that rapid intracellular lysis of Shigella flexneri, provoked by either the use of a diaminopimelic acid auxotroph mutant or treatment of infected cells with antibiotics of the beta-lactam family, resulted in a massive and rapid induction of apoptotic cell death. This intracellular bacteriolysis-mediated apoptotic death (IBAD) was characterized by the specific involvement of the mitochondrial-dependent cytochrome c/Apaf-1 axis that resulted in the activation of caspases-3, -6 and -9. Importantly, Bcl-2 family members and the NF-kappaB pathway seemed to be critical modulators of IBAD. Finally, we identified that IBAD was also triggered by Salmonella enterica serovar Typhimurium but not by the Gram-positive bacteria, Listeria monocytogenes. Together, our results demonstrate that, contrary to previous findings, epithelial cells are intrinsically able to mount an efficient apoptotic cell death response following infection. Indeed, apoptosis in normal circumstances is masked by powerful anti-apoptotic mechanisms, which are overcome in IBAD. Our results also uncover an unexpected consequence of the treatment of infected cells with certain classes of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606244     DOI: 10.1016/j.micinf.2008.06.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol.

Authors:  John-Demian Sauer; Chelsea E Witte; Jason Zemansky; Bill Hanson; Peter Lauer; Daniel A Portnoy
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

2.  Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation.

Authors:  Ida Paciello; Alba Silipo; Luigi Lembo-Fazio; Laura Curcurù; Anna Zumsteg; Gaëlle Noël; Valeria Ciancarella; Luisa Sturiale; Antonio Molinaro; Maria Lina Bernardini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

3.  Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo.

Authors:  L Lembo-Fazio; G Nigro; G Noël; G Rossi; F Chiara; K Tsilingiri; M Rescigno; A Rasola; M L Bernardini
Journal:  Cell Death Dis       Date:  2011-02-24       Impact factor: 8.469

4.  Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines.

Authors:  Alexander Bartel; André Göhler; Verena Hopf; Katrin Breitbach
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

5.  Alteration of epithelial cell lysosomal integrity induced by bacterial cholesterol-dependent cytolysins.

Authors:  Julien Karim Malet; Pascale Cossart; David Ribet
Journal:  Cell Microbiol       Date:  2016-11-21       Impact factor: 3.715

6.  IFN-γ extends the immune functions of Guanylate Binding Proteins to inflammasome-independent antibacterial activities during Francisella novicida infection.

Authors:  Pierre Wallet; Sacha Benaoudia; Amandine Mosnier; Brice Lagrange; Amandine Martin; Helena Lindgren; Igor Golovliov; Fanny Michal; Pauline Basso; Sophia Djebali; Angelina Provost; Omran Allatif; Etienne Meunier; Petr Broz; Masahiro Yamamoto; Bénédicte F Py; Eric Faudry; Anders Sjöstedt; Thomas Henry
Journal:  PLoS Pathog       Date:  2017-10-02       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.